دورية أكاديمية

OAB-048: Suboptimal humoral immune response to SARS-CoV-2 mRNA vaccination in myeloma patients is associated with anti-CD38 mAb and BCMA-targeted treatment

التفاصيل البيبلوغرافية
العنوان: OAB-048: Suboptimal humoral immune response to SARS-CoV-2 mRNA vaccination in myeloma patients is associated with anti-CD38 mAb and BCMA-targeted treatment
المؤلفون: Oekelen, Oliver Van, Agte, Sarita, Gleason, Charles, Srivastava, Komal, Beach, Katherine, Aleman, Adolfo, Upadhyaya, Bhaskar, Kappes, Katerina, Mouhieddine, Tarek, Wang, Bo, Chari, Ajai, Cordon-Cardo, Carlos, Krammer, Florian, Jagannath, Sundar, Simon, Viviana, Wajnberg, Ania, Parekh, Samir
المصدر: Clinical Lymphoma Myeloma and Leukemia ; volume 21, page S30-S31 ; ISSN 2152-2650
بيانات النشر: Elsevier BV
سنة النشر: 2021
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
مصطلحات موضوعية: Cancer Research, Oncology, Hematology
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/s2152-2650(21)02122-4
الإتاحة: https://doi.org/10.1016/s2152-2650Test(21)02122-4
https://api.elsevier.com/content/article/PII:S2152265021021224?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2152265021021224?httpAccept=text/plainTest
حقوق: https://www.elsevier.com/tdm/userlicense/1.0Test/
رقم الانضمام: edsbas.73C24CF1
قاعدة البيانات: BASE